Biocon · NSE: BIOCON · BSE: 532523
Q1 FY27 results · Apr–Jun 2026
Biocon reported revenue from operations of ₹4,336.00 crore (up 10.0% from Q1 FY26) and net profit of ₹136.80 crore (up 53.4% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a consolidated basis.
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 4,336.00 | 3,941.90 | +10.0% | 4,516.60 | −4.0% |
| Other income | 54.50 | 79.70 | −31.6% | 52.50 | +3.8% |
| Total income | 4,390.50 | 4,021.60 | +9.2% | 4,569.10 | −3.9% |
| Profit before tax | 127.60 | 96.90 | +31.7% | 247.50 | −48.4% |
| Net profit for the period | 136.80 | 89.20 | +53.4% | 198.60 | −31.1% |
| Attributable to shareholders of the company | 141.10 | 31.40 | +349.4% | 125.90 | +12.1% |
| EPS, basic (₹) | 0.87 | 0.26 | not comparable | 0.79 | +10.1% |
| Net margin (%) | 3.2 | 2.3 | 4.4 |
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 624.50 | 537.10 | +16.3% | 604.70 | +3.3% |
| Other income | 64.80 | 61.30 | +5.7% | 49.80 | +30.1% |
| Total income | 689.30 | 598.40 | +15.2% | 654.50 | +5.3% |
| Profit before tax | 69.90 | (7.60) | Turned profit | 57.40 | +21.8% |
| Net profit for the period | 52.20 | (8.30) | Turned profit | 51.00 | +2.4% |
| EPS, basic (₹) | 0.32 | (0.07) | not comparable | 0.32 | +0.0% |
| Net margin (%) | 8.4 | -1.5 | 8.4 |
Consolidated
- Filed with BSE
- 05 Aug 2026, 17:20 IST
- Board meeting
- 05 Aug 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 05 Aug 2026, 17:20 IST
- Board meeting
- 05 Aug 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE